Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001214659-25-012265·Bolt Biotherapeutics, Inc.
Schedule 13G ownership disclosure
BOLT BIOTHERAPEUTICS INC
Common Stock, par value $0.00001 per share · CUSIP: 097702203
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TANG CAPITAL MANAGEMENT, LLC
Shares: 166,879.00 · Class: 8.7%
- KEVIN TANG
Shares: 166,879.00 · Class: 8.7%
- TANG CAPITAL PARTNERS, LP
Shares: 93,913.00 · Class: 4.9%
- TANG CAPITAL PARTNERS INTERNATIONAL, LP
Shares: 72,966.00 · Class: 3.8%
- TANG CAPITAL PARTNERS III, INC
Shares: 0.00 · Class: 0.0%
- TANG CAPITAL PARTNERS IV, INC
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-25-012265
- Form type
- SCHEDULE 13G/A
- Filer
- Bolt Biotherapeutics, Inc.
- CIK
- CIK 1641281
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership